Acquisitions /mergers/joint-ventures   Horizon launches a $3 billion hostile takeover bid over Depomed Horizon Pharma (Dublin, Pharma) now made its takeover offer straight to Depomed (Newark, NJ, USA) shareholders after its initial approach was turned down by Depomed’s management. The offer consists in the acquisition of all outstanding shares of Depomed for $29.25 a share […]

Acquisitions /mergers/joint-ventures Mylan still active on the Perrigo bid Analysts believe that the current offer of $75 per share in cash and 2.3 Mylan share for each Perrigo share is unlikely to change. Mylan says it still thinks it's possible to work something out directly with Perrigo and thus protect itself from a Teva takeover. […]